Eli Lilly Agrees to Acquire Merida Biosciences for $2.88 Billion
Pharmaceutical company Eli Lilly plans to buy autoimmune disease specialist Merida Biosciences in cash to expand its therapeutic portfolio beyond weight-loss drugs.
Results for "Merida Biosciences"
4 stories found
Eli Lilly to Acquire Merida Biosciences for Up to $2.88 Billion
Eli Lilly has agreed to purchase biotech firm Merida Biosciences in a cash deal valued at up to $2.88 billion. The acquisition is designed to accelerate the development of novel therapies targeting serious autoimmune and allergic conditions.
World5d ago
Lilly to Buy Merida for $2.88 Billion in Autoimmune Push
Eli Lilly & Co. plans to buy Merida Biosciences Inc. for as much as $2.88 billion in cash to expand in autoimmune and allergic diseases, part of an effort to build beyond the weight-loss and diabetes…
Eli Lilly Acquires Merida Biosciences to Expand Diabetes Drug Portfolio
The American pharmaceutical giant Eli Lilly has purchased Merida Biosciences in a multi-billion dollar deal aimed at strengthening its immunology and weight-loss medication pipeline.